# Effectiveness and Safety of Mirikizumab in Patients With Moderate-to-severe Ulcerative Colitis: a Real-life Retrospective Multicenter Study

> **NCT07695636** · — · COMPLETED · sponsor: **IRCCS San Raffaele** · enrollment: 282 (actual)

## Conditions studied

- Ulcerative Colitis (UC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07695636
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07695636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07695636, "Effectiveness and Safety of Mirikizumab in Patients With Moderate-to-severe Ulcerative Colitis: a Real-life Retrospective Multicenter Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07695636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*